Neurocrine Biosciences NBIX
$ 124.93
1.33%
Quarterly report 2024-Q3
added 10-30-2024
Neurocrine Biosciences EV/EBITDA Ratio 2011-2024 | NBIX
Annual EV/EBITDA Ratio Neurocrine Biosciences
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
69.1 | 29.3 | 41 | 198 | -60.3 | -23.3 | -37.8 | -39 | -22.5 | 244 | 13.3 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
244 | -60.3 | 37.5 |